2018 ACR/ARHP Annual Meeting Archives - Page 123 of 202

Abstract Number: 1613

Dactylitis in Early Spondyloarthritis. Baseline Data from a Prospective French National Cohort
Abstract Number: 589

DAS28-CRP Versus DAS28-ESR and Thresholds for Disease Activity Category: Blinded Data from the Ongoing Phase IIb Trial with the EP4 Receptor Antagonist CR6086 in DMARD-Naïve Patients with Early Rheumatoid Arthritis
Abstract Number: 99

DC-Hil+ Myeloid-Derived Suppressor Cells Are Elevated in the Peripheral Blood and Lesional Skin of Cutaneous Lupus Patients
Abstract Number: 2948

Deconstructing the in Situ Myeloid Cell Microenvironment in Human Lupus Nephritis Tissue
Abstract Number: 78

Decreased B Cell Ataxia-Telangiectasia Mutated Expression and Receptor Diversity Identify a Subset of Rheumatoid Arthritis Patients with Increased Joint Erosion Prevalence
Abstract Number: 1392

Decreased Injection Site Pain Associated with New Etanercept Formulation in Patients with Rheumatoid Arthritis or Psoriatic Arthritis
Abstract Number: 1447

Decreased Lymphatic Drainage in the Hands of Flaring RA Patients As Measured By Indocyanine Green Clearance Via Real Time Near Infrared Imaging
Abstract Number: 176

Deductive Anatomy By Self-Examination. a Novel Method to Reinforce Traditional Teaching of Musculoskeletal Anatomy
Abstract Number: 175

Deductive Anatomy By Self-Examination. Preliminary Evaluation of a Novel Method to Reinforce Knowledge of Musculoskeletal Anatomy at the 2018 Panlar Meeting
Abstract Number: 149

Deep Immune-Profiling of CD4+ T Cells in Behçet’s Disease
Abstract Number: 2426

Defining a Standardized Core Data Set for Pregnancy Registers in Rheumatic Diseases – an European Approach
Abstract Number: 2182

Defining Alendronate Drug Holidays and Re-Initiation in US Medicare Data
Abstract Number: 1845

Defining and Examining Retention in Care in an Urban Lupus Cohort
Abstract Number: 2258

Defining Characteristics of Patients with Overlap between Sarcoidosis and Connective Tissue Diseases
Abstract Number: 965

Defining Cutoffs Corresponding to Low Levels of Disease Activity in Psoriatic Arthritis, Using the Patient-Reported Psoriatic Arthritis Impact of Disease Questionnaire (PsAID12). an Analysis of 436 Patients
Abstract Number: 1918

Defining Pain That Does Not Interfere with Activities Among Rheumatoid Arthritis (RA) Patients
Abstract Number: 906

Defining the Gut Microbiome in Patients with ANCA-Associated Vasculitis
Abstract Number: 674

Defining the Therapeutic Target in Psoriatic Arthritis: MDA Versus Dapsa
Abstract Number: 2703

Delay in Initiation of Therapy Predicts Worse Outcomes in Scleroderma Renal Crisis
Abstract Number: 911

Demographic and Clinical Characteristics Reflect Differences in Osteoarthritis Phenotypes of the Lumbar Spine: The Johnston County Osteoarthritis Project
Abstract Number: 796

Demographic and Clinical Features of Systemic Sclerosis Patients with Anti-U1RNP Antibodies: A European Scleroderma Trials and Research (EUSTAR) Analysis
Abstract Number: 31

Dendritic Cell-Specific Transmembrane Protein (DC-STAMP) Regulates Inflammation and Joint Damage in the TNF-Tg Mouse Model
Abstract Number: 90

Deoxyribonuclease 1-like-3 Digests Self-DNA from Dead Cells and Prevents Autoimmunity
Abstract Number: 1598

Depression and Anxiety Reduce Probability of Achieving a State of Minimal Disease Activity in Patients with Psoriatic Arthritis
Abstract Number: 1389

Depression and the Patient Reported Outcomes Measurement Information System in Systemic Lupus Erythematosus
Abstract Number: 1660

Depression Has a Greater Impact on Psoriatic Arthritis Than Rheumatoid Arthritis
Abstract Number: 1510

Depression Is a Major Driver of Functional Capacity in Patients with Rheumatoid Arthritis Regardless of Disease Activity
Abstract Number: 292

Derivation of a National Rheumatoid Arthritis Cohort in the Veterans Health Administration and Validation with the Veterans Affairs Rheumatoid Arthritis Registry
Abstract Number: 938

Dermal Lymphatic Dysfunction and Photosensitivity in the MRL/Lpr Lupus Model
Abstract Number: 876

Dermatomyositis Skin Shares Type I Interferon Overlap with Cutaneous Lupus but Displays Many Unique Expression Changes That May Serve As Biomarkers for Skin Disease
Abstract Number: 2590

Descriptive Comparisons of the Impact of Apremilast and Methotrexate Monotherapy in Patients with Oligoarticular Psoriatic Arthritis in the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
Abstract Number: 1738

Detect Outperforms Echocardiography Based Screening Guidelines for Early Detection of Systemic Sclerosis Associated Pulmonary Arterial Hypertension
Abstract Number: 2207

Detecting Hand Joint Ankylosis in Radiographic Images Using Deep Learning: A Step in Development of Automatic Radiographic Scoring System for Bone Destruction
Abstract Number: 1370

Detection of an Autoantibody Profile to Characterize Patients with Early (Pre-symptomatic) Knee Osteoarthritis: Data from the Osteoarthritis Initiative
Abstract Number: 1967

Detection of Association of Long Noncoding RNA ATP6V0E2-AS1 Single Nucleotide Polymorphism with Susceptibility to Myeloperoxidase-ANCA Associated Vasculitis Based on Transcriptome Analysis
Abstract Number: 2216

Detection of Left Ventricular Regional Function in Primary Sjögren’s Syndrome Patients without Cardiac Symptons, As Assessed By Feature Tracking Cardiac Magnetic Resonance Imaging
Abstract Number: 1052

Detection of Precursors of RANK- Osteoclast-like Cells (Olcs) in Peripheral Blood and Olcs in Bone Tissue from Rheumatoid Arthritis Patients
Abstract Number: 2964

Detection of Uric Acid Crystals in the Vasculature of Patients with Gout Using Dual-Energy Computed Tomography
Abstract Number: 754

Determinants of Major Neurocognitive Disorder (Vascular Dementia) in SLE: The Importance of Treatment Adherence of SLE Disease Activity and Cardiovascular Risk Factors
Abstract Number: 2496

Determination of the Minimally Important Difference for Interpreting the RA Multi-Biomarker Disease Activity Test Score: Impact of Diurnal and Daily Biomarker Variation on Scores Adjusted for Age, Sex and Adiposity
Abstract Number: 2410

Determining the Need for Fatigue Management Resources for Young Adults with Rheumatic Disease
Abstract Number: 1263

Develop a Master Algorithm for Drug Withdraw Strategy in Reduction of Adverse Events – a Machine Learning Model from the Smart System of Disease Management (SSDM)
Abstract Number: 2194

Develop a New Platform for Post-Marketing Vigilance Though Smart System of Disease Management (SSDM) Mobiles Tools: A Real World Cohort Study of RA Patients from China
Abstract Number: 1037

Develop an in Vitro Model to Test the Different Behavior of mtDNA in OA and Healthy Patients, Based on Mitochondrial Activity and Metabolic Response
Abstract Number: 2298

Developing a Classification Criteria for Cutaneous Dermatomyositis Utilizing the Delphi Technique
Abstract Number: 1261

Development a Core Domain Set to Assess Shared Decision Making Interventions in Rheumatology: An OMERACT White Paper to Facilitate Endorsement
Abstract Number: 2181

Development and Feasibility of a Web-Based Data Capture System to Collect Uniform Comprehensive Post-Total Knee Replacement Physical Therapy Intervention Data for Both Clinical and Research Purposes
Abstract Number: 2671

Development and First-in-Human Characterization of an ICOSL and BAFF Bispecific Inhibitor AMG 570 for SLE Treatment
Abstract Number: 331

Development and Implementation of a Patient-Reported Outcomes Measurement Information System (MyRheum)
Abstract Number: 1394

Development and Pilot of a Patient Satisfaction Scale in Rheumatology
Abstract Number: 314

Development and Preliminary Validation of an Omeract Magnetic Resonance Imaging (MRI) Scoring System for Ankle Enthesitis in Spondyloarthritis
Abstract Number: 1860

Development and Validation of a Microrna Panel to Differentiate between Patients with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Control Subjects
Abstract Number: 2474

Development of a Crosswalk for FACIT-10 (Psychometric Work)
Abstract Number: 320

Development of a Magnetic Resonance Imaging Atlas for the Classification of Osteoarthritis of the First Metatarsophalangeal Joint
Abstract Number: 2816

Development of a Microrna Panel for Predicting Coronary Atherosclerosis in Rheumatoid Arthritis
Abstract Number: 1042

Development of a Neo-Epitope Specific Assay for Serological Assessment of Type X Collagen Degradation and Its Potential Diagnostic Value for Knee Osteoarthritis
Abstract Number: 2141

Development of a Pediatric Glucocorticoid Toxicity Index
Abstract Number: 1455

Development of a Predictive Model of Radiological Damage in Patients with Rheumatoid Arthritis Based on Artificial Intelligence
Abstract Number: 2910

Development of a Rheumatoid Arthritis Global Outcome Measure to Enable Comparisons of Patient Experiences across Treatment Arms in Randomized Clinical Trials
Abstract Number: 2959

Development of a Set of Potentially Preventable Adverse Conditions Specific to Lupus: A Delphi Consensus Study
Abstract Number: 2514

Development of a Subcutaneous Formulation of CT-P13 (Infliximab): Maintenance Subcutaneous Administration May Elicit Lower Immunogenicity Compared to Intravenous Treatment
Abstract Number: 999

Development of an Affimab Engineered to Simultaneously Target IL-6 and Tnfα for Therapeutic Use in Rheumatoid Arthritis
Abstract Number: 281

Development of an African American Lupus Community-Based Patient and Provider Education Program: Lupus Conversations
Abstract Number: 209

Development of an Algorithm for the Classification of Cardiovascular Comorbidity in Rheumatoid Arthritis: Data from the Ontario Best Practices Research Initiative
Abstract Number: 1706

Development of an Online Lupus Self-Management Program Based on the Transtheoretical Model of Change
Abstract Number: 184

Development of Focused Musculoskeletal Ultrasound Training for Primary Care Providers to Facilitate the Diagnosis of Gout: Initial Steps in an Educational Needs Assessment
Abstract Number: 1559

Development of Lymphoma in Patients with Sjogren’s Syndrome
Abstract Number: 163

Development of New International Classification Criteria for Antiphospholipid Syndrome: Phase II Item Reduction Survey
Abstract Number: 816

Development of Thoracic Aortic Aneurysms in Patients with Polymyalgia Rheumatica: Underdiagnosed Giant Cell Arteritis?
Abstract Number: 242

DHEA Deficiency in Fibromyalgia
Abstract Number: 1368

Diabetes Mellitus Is Not a Risk Factor for Knee Osteoarthritis, a Systematic Review and Meta-Analysis
Abstract Number: 1229

Diagnosing Prosthetic Joint Infections in Patients with Inflammatory Arthritis
Abstract Number: 760

Diagnosing SLE Arthritis with Dynamic Diffuse Optical Spectroscopy
Abstract Number: 1835

Diagnosis of Fibromyalgia: Disagreement between Fibromyalgia Criteria and Clinician-Based Fibromyalgia Diagnosis in a University Clinic
Abstract Number: 2155

Diagnosis of Systemic Sclerosis in the United Kingdom: An Observational Study Using the Clinical Practice Research Datalink
Abstract Number: 2962

Diagnostic Accuracy of Gout in Electronic Health Records and the Role of Rheumatology Electronic Consults
Abstract Number: 1735

Diagnostic Accuracy of MR Angiography in a Cohort with Systemic Sclerosis Compared to Other Rheumatic Diseases with Acral Hypoperfusion
Abstract Number: 2909

Diagnostic and Prognostic Value of Ultrasound Compared with Plain Radiography in Knee Osteoarthritis
Abstract Number: 2773

Diagnostic and Therapeutic Management of a Suspected Case of GCA: An Opinion Survey
Abstract Number: 638

Diagnostic Delay and Associated Factors in Axial Spondyloarthritis across Europe. Results from the European Map of Axial Spondyloarthritis Survey
Abstract Number: 266

Diagnostic Delays and Disparities in Access to Care in Systemic Lupus Erythematosus
Abstract Number: 1569

Diagnostic Performance of Labial Salivary Gland Biosy, Serological and Clinical Data in Sjogrens Syndrome. in Argentinian Multicenter
Abstract Number: 655

Diagnostic Performance of MRI Lesions in the Sacroiliac Joints According to Updated Assessments in Spondyloarthritis International Society Lesion Definitions: A Central Reader Assessment of MRI Scans from the Assessments in Spondyloarthritis Classification Cohort
Abstract Number: 1441

Diagnostic Performances of Antibodies Against Carbamylated Proteins in US Based Populations with Rheumatoid Arthritis and Other Autoimmune Rheumatic Diseases
Abstract Number: 1310

Diagnostic Utility of Myositis Antibodies in Patients with Interstitial Lung Disease and Suspected Underlying Connective Tissue Disease
Abstract Number: 312

Diagnostic Value of MRI in Non-Radiographic Axial Spondyloarthritis
Abstract Number: 805

Diastolic Dysfunction in Scleroderma: An Investigation into Associated Risk Factors and Impact on Survival
Abstract Number: 2321

Dickkopf-1 Serum Levels in Patients with Systemic Sclerosis and Correlation with Trabecular Bone Score
Abstract Number: 1132

Diet Modification for Gout Patients: Effects on Gout Attacks and Risk Factors for Metabolic Syndrome
Abstract Number: 64

Dietary Magnesium Modulates the Intestinal Microbiome and T Cell Subsets
Abstract Number: 1695

Differences between Early and Adult-Onset Systemic Lupus Erythematosus in Cohort of Argentinian Patients
Abstract Number: 386

Differences in Body Composition in Myositis Patients and Healthy Controls Are Associated with Disease Activity and Duration, Inflammatory Status, Skeletal Muscle Involvement and Physical Activity
Abstract Number: 2961

Differences in Healthcare Transition Views, Practices, and Barriers Among North American Pediatric Rheumatology Providers from 2010 to 2018
Abstract Number: 2180

Differences in Longitudinal Disease Activity Measures between Research Cohort and Non-Cohort Participants with Rheumatoid Arthritis Using Electronic Health Record Data
Abstract Number: 1407

Differences in the Measurement Properties of the Patient-Reported Outcomes Measurement Information System Physical Function Short-Form 10a Among Racial/Ethnic Minorities with Rheumatoid Arthritis
Abstract Number: 1035

Different Cartilage-Bone Unit in Patients with Primary Osteoarthritis and Secondary Osteoarthritis Caused By Rheumatoid Arthritis
Abstract Number: 2023

Different Patterns of Interferon-Response-Gene Expression May Elucidate Different Pathomechanisms That Drive IFN-Response-Gene Activation in Patients with Presumed IFN-Mediated Autoinflammatory Diseases
Abstract Number: 2673

Different Risk Profiles for Development of Steroid-Related and Steroid-Unrelated Damage in Early Diagnosed SLE: Results from the Italian Multicenter Early Lupus Project Inception Cohort
Abstract Number: 709

Differential Characteristics of Lupus Psychosis and Steroid Psychosis
Abstract Number: 1442

Differential Chemical Isotope Labeling Liquid Chromatography Mass Spectrometry and a Universal Metabolome Standard Reveals a Metabolome Profile with Consistent Accuracy for Rheumatoid Arthritis
Abstract Number: 844

Differential Roles of Tnfα-TNFR1 and Tnfα-TNFR2 in the Differentiation and Function of Induced CD4+Foxp3+ Treg Cells in Autoimmune Diseases
Abstract Number: 1059

Differentially-Utilized Transcription Factors and Enhancers in Rheumatoid Arthritis (RA) Fibroblast-like Synoviocytes
Abstract Number: 2263

Differentiated Phenotypes at Diagnosis of Sarcoidosis According to the Scadding Classification: Analysis in 1230 Patients
Abstract Number: 407

Digital Disruptive Technology for Rehabilitation Following Elective Surgery for Low Back Pain, Knee and Hip Osteoarthritis: A Systematic Review and Meta-Analysis
Abstract Number: 2837

Diminished STAT-3 Phosphorylation and Associated Cell Pathways Characterize MMF-Treated Systemic Lupus Erythematosus Patients
Abstract Number: 126

Direct Interaction between Autoreactive B Cells and Endothelial Colony Forming Cells Induces Cytokine Production from B Cells through B Cell Receptor and IL-6-JAK2-STAT3 Signaling Pathway, Suppressing Proliferation of Endothelial Colony Forming Cells in Systemic Sclerosis
Abstract Number: 2185

Direct Medical Costs for Medicare Patients with Rheumatoid Arthritis
Abstract Number: 229

Disability Status, Mortality, and Leading Causes of Death in Seropositive Rheumatoid Arthritis Patients: A Population-Based Study in Korea
Abstract Number: 2953

Disappearance of Autoantibodies in RA: Does It Occur with Current Treatment Strategies? a Long-Term Follow-up Study in Patients That Achieved DMARD-Free Sustained Remission
Abstract Number: 698

Discontinuation of Methotrexate or TNF Inhibitors in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
Abstract Number: 1881

Discovery and Validation of Novel Disease Subsets in 806 Patients with Takayasu’s Arteritis across Four International Cohorts
Abstract Number: 37

Discovery of DWP213388, a Potent ITK and BTK Dual Target Inhibitor with Excellent Efficacy, As a Treatment for Autoimmune Diseases
Abstract Number: 2706

Discriminant Validity and Reliability of World Scleroderma Foundation (WSF) Definition of Skin Ulcers in Systemic Sclerosis
Abstract Number: 447

Discriminating between Central & Peripheral Pain Sensitization Using a Slowly Repeated Evoked Pain Protocol
Abstract Number: 2860

Disease Activity and Its Measurement in Patients with RA across the U.S.: Data from the Rheumatology Informatics System for Effectiveness (RISE) Registry
Abstract Number: 1840

Disease Activity in Rheumatoid Arthritis Patients Is Influenced By Countries’ Socioeconomics: Results from the Meteor Registry
Abstract Number: 2501

Disease Activity Is the Major Discriminator When Defining Refractory Rheumatoid Arthritis
Abstract Number: 614

Disease Activity One Year after Addition of Bucillamine or Sulfasaladine to Methotrexate in Japanese Patients with Rheumatoid Arthritis : Propensity Score Analysis
Abstract Number: 2633

Disease Activity, Organ Damage and Patient-Reported Outcome Measures in Swedish Patients with Recent-Onset SLE
Abstract Number: 1602

Disease Characteristics, Quality of Life, and Work Productivity By Enthesitis Sites: Real-World Data from the US Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry
Abstract Number: 1670

Disease Course Patterns in Systemic Lupus Erythematosus: Impact on Long-Term Outcomes
Abstract Number: 1741

Disease Duration and Autoantibodies Predict Distinct Skin Score Trajectories in Diffuse Cutaneous Systemic Sclerosis
Abstract Number: 652

Disease Interception in Psoriasis Patients with Subclinical Joint Inflammation By Interleukin 17 Inhibition with Secukinumab – Data from a Prospective Open Label Study
Abstract Number: 543

Disease Severity Among Bio-Naive RA Patients on Csdmards
Abstract Number: 1742

Disease-Specific Autoantibodies Associate with Remarkably Different Risk of Development of Significant Lung Fibrosis in Systemic Sclerosis
Abstract Number: 2646

Disparities in Antimalarial Prescribing for Systemic Lupus Erythematous Nephritis Using a Real-World, Electronic Health Record
Abstract Number: 265

Disparities in Utilization and Direct Costs of Hospitalizations and Emergency Room Visits in SLE: The Georgia Lupus Registry
Abstract Number: 221

Distal Interphalangeal Joint Involvement and Its Association with Disease Activity in Rheumatoid Arthritis (RA): Analysis Based on a Nationwide RA Database in Japan
Abstract Number: 1046

Distinct Balance of TNF-α/IL-10 in Circulating and Infiltrating CD163+ Macrophages between Rapidly and Slowly Progressive Symptomatic Knee Osteoarthritis
Abstract Number: 1014

Distinct Macrophage Phenotype and Bioenergetic Profiles in Rheumatoid Arthritis
Abstract Number: 1074

Distinct Metabolic Profile in the Urine of Rheumatoid Arthritis Patients:a Possible Link to Arthritis Phenotypes
Abstract Number: 1113

Distinct Pathways in Anti-RNP-Associated Pulmonary Hypertension and Anti-RNP-Associated Raynaud’s Phenomenon
Abstract Number: 138

Distinct Roles of Tfh2, SLAMF7+ Tfh1 Cells and Th1 Cells in the Pathogenesis of IgG4-RD
Abstract Number: 207

Divergent Patterns of Cardiovascular Risk in Biomarkers of Lipids and Subclinical Myocardial Injury during Increased Inflammation in Rheumatoid Arthritis
Abstract Number: 1520

DMARD Hepatotoxicity in Rheumatoid Arthritis and Its Association with the Surrogates of Metabolic Syndrome
Abstract Number: 622

DMARD Withdrawal in RA Patients Achieving Therapeutic Response with Certolizumab Pegol Combined with Dmards: Results from a Canadian Randomized Study
Abstract Number: 829

DNA Damage and Repair in Patients with Cryoglobulinemic Vasculitis Treated with Direct Anti-HCV Drugs
Abstract Number: 74

DNA Methylation of the Dual Specificity Protein Phosphatase 22 (DUSP22) Gene Promoter in Plasma of Patients with Seropositive and Seronegative RA
Abstract Number: 2478

Do Age and Education Influence the Disease Activity Score? an Explorative Analysis in the Norwegian Register of Dmards
Abstract Number: 1463

Do Anti-Citrullinated Protein Antibodies and Anti-Sjögren’s-Syndrome-Related Antigen a Double Positive Patients with Secondary Sjögren’s Syndrome and RA Have Higher Joint Disease Activity?
Abstract Number: 1947

Do Changes in Pain Sensitization and Depressive Symptoms Mediate the Effect of Extreme Weight Loss on Knee Pain Improvement?
Abstract Number: 2409

Do Children with Juvenile Idiopathic Arthritis Play an Active Role in Their Treatment Adherence? First Results of the Rumaji Study
Abstract Number: 646

Do Ethnicity, Degree of Family Relationship, and the Spondyloarthritis Subtype in Affected Relatives Influence the Association between a Positive Family History for Spondyloarthritis and HLA-B27 Carriership? Results from the Worldwide ASAS Cohort
Abstract Number: 313

Do Musculoskeletal Ultrasound and Magnetic Resonance Imaging Identify Synovitis and Tenosynovitis at the Same Joints and Tendons? – a Comparative Study in Patients Presenting with Early Arthritis and Clinically Suspect Arthralgia
Abstract Number: 2856

Do Patients with Moderate or High Disease Activity Escalate RA Therapy According to Treat-to-Target Principles? Results from the Acr’s RISE Registry
Abstract Number: 2990

Do Polymyalgia Rheumatica Patients Have an Increased Risk of Cardiovascular Events?: A Matched-Control Study
Abstract Number: 2859

Do Preventive Cardiology Consults Versus Usual Care Improve Cardiovascular Risk Factor Assessment and Management in Patients with Rheumatoid Arthritis?
Abstract Number: 1927

Do Remission and Low Disease Activity State Go Hand in Hand with Patient’s Perception of Disease Burden and Quality of Life in Systemic Lupus Erythematosus?
Abstract Number: 1630

Do Symptoms of Depression and Anxiety Influence Treatment Response and Long-Term Physical Health Outcomes in Ankylosing Spondylitis?
Abstract Number: 2108

Dock8-Positive CD4 T Cell As Autoantibody-Inducing CD4 T (aiCD4 T) Cell That Causes Systemic Lupus Erythematosus (SLE): Proof of Concept of Self-Organized Criticality Theory As a Cause of SLE
Abstract Number: 339

Documenting Bone Health for Veterans with Rheumatoid Arthritis in an Outpatient Academic Clinic
Abstract Number: 337

Does a Best Practice Alert Improve RA Patient Referral to Preventative Cardiology?
Abstract Number: 2200

Does an 18f-FDG-PET/CT in Patients with Giant Cell Arteritis in Clinical Remission Make Sense?
Abstract Number: 544

Does Anti-Citrullinated Protein Antibody Status Modify Treatment Effect of Certain Biologic DMARDs?
Abstract Number: 826

Does Anti-Glomerular Basement (anti-GBM) Antibody Positivity Correlate with Relapse in Patients with Anti-GBM Disease?
Abstract Number: 296

Does Care By a Multidisciplinary Team Improve Outcomes in Rheumatoid Arthritis? a Randomized Controlled Study
Abstract Number: 771

Does Cognitive Function Change over-Time in Systemic Lupus Erythematosus?
Abstract Number: 2842

Does Leflunomide Have a Role in Giant Cell Arteritis?
Abstract Number: 437

Does Reduction in Mechanical Knee Joint Loading Explain the Beneficial Effects of Weight Loss in Overweight or Obese Patients with Knee Osteoarthritis?
Abstract Number: 1944

Does Renin Angiotensin System Blockade in Addition to Immunosuppressive Therapy Improve Proteinuria in Acute Lupus Nephritis?
Abstract Number: 1326

Does Testing for SAA Is More Beneficial Than CRP for the Follow-up of Patients with Familial Mediterranean Fever ?
Abstract Number: 2999

Does the Incremental Cost of ACPA-Positive Rheumatoid Arthritis Patients Vary By the Care Pathway They Follow?
Abstract Number: 2821

Dose Tapering and Discontinuation of Biological Therapy in Rheumatoid Arthritis Patients in Routine Care – 2-Year Outcomes and Predictors
Abstract Number: 418

Dose-Response Relationship between Neuromuscular Electrical Stimulation and Muscle Function in Patients with Rheumatoid Arthritis
Abstract Number: 1899

Down-Regulation of RNA Processing Protein CFIm25 Amplifies Skin Fibrosis By up-Regulating Pro-Fibrotic Transcripts/Proteins in Systemic Sclerosis
Abstract Number: 1112

Downregulated Expression of Interferon Regulatory Factor 8 in Circulating Monocytes Exhibits Pro-Fibrotic Phenotype in Patients with Systemic Sclerosis
Abstract Number: 1058

Doxycycline Directly Scavenges Reactive Oxygen Species and Inhibits the Formation of Malondialdehyde-Acetaldehyde-Protein Adducts – a Novel Mechanism of Action for an Old Drug
Abstract Number: 1259

Driving Performance and Safety in Rheumatoid Arthritis: A Systematic Review
Abstract Number: 2605

Drug Retention and Response Rates of TNFi Treatment in 13,170 Patients with Psoriatic Arthritis Treated in Routine Care – Pooled Data from the Eurospa Research Network Collaboration
Abstract Number: 1867

Drug Retention and Response Rates of TNFi Treatment in 21,470 Patients with Axial Spondyloarthritis Treated in Clinical Practice– Pooled Data from the Eurospa Research Network Collaboration
Abstract Number: 2618

Drug Survival of Non TNF Inhibitors Bdmards in Psoriatic Arthritis (Ustekinumab/Secukinumab) : A Real-Word Multicentric Cohort of 161 Patients
Abstract Number: 552

Drug Tolerability and Discontinuation Reasons of 7 Biologics in 4466 Treatment Courses of Rheumatoid Arthritis -the Answer Cohort Study-
Abstract Number: L17

Dual Neutralization of IL-17A and IL-17F with Bimekizumab in Patients with Active Psa: Results from a 48-Week Phase 2b, Randomized, Double‑Blind, Placebo-Controlled, Dose-Ranging Study
Abstract Number: 1275

Dual-Energy CT for the Diagnosis of Gout: A Prospective Study in Patients with No Prior History of Gout
Abstract Number: 2942

Dyadic Study of Partner Social Support for Physical Activity and Its Role in the Initiation and Maintenance of Increased Physical Activity Among Insufficiently Active People with Hip/Knee Osteoarthritis
Abstract Number: 2002

Dynamic Compression of Articular Cartilage Explants Increases Formation and Decreases Degradation of Type II Collagen
Abstract Number: 304

Dynamic MRI in Rheumatoid Arthritis for the Assessment of Synovitis Promoting Cartilage Loss
Abstract Number: 2777

Dynamics in Peripheral Blood Cell Counts in Giant Cell Arteritis before Treatment, during Treatment and in Treatment-Free Remission
Abstract Number: 1974

Dynamics of Transcriptional Signatures from Synovial Macrophage Subsets during Acute and Chronic Murine Models of Inflammatory Arthritis
Abstract Number: 2079

Dysbiosis of Gut Microbiomes in Ankylosing Spondylitis
Abstract Number: 2067

Dysbiosis-Dependent Inflammasomes Activation Drives Innate Immune Responses in Ankylosing Spondylitis Patients
Abstract Number: 1084

Dysfunction of the DNASE1L3 Pathway and Antigen Accumulation in Lupus Nephritis
Abstract Number: 1330

Dyskeratotic Cells in Persistent Pruritic Skin Lesions Are Apoptotic and Associated with High Levels of Serum IL-18, and Possibly Predict the Outcomes in Adult-Onset Still’s Disease
Abstract Number: 2081

Dysregulated MiR-125a Promotes Joint Angiogenesis in Psoriatic Arthritis through Altered Bioenergetics
Abstract Number: 2031

Dysregulated NK Cell PLC